Not registered yet? Please contact our project manager Dr. Sara Stöber . This area is only for members of the research consortium.

Advisory boards

Advisory boards

Scientific and Ethical Advisory Board (SEAB)

The Scientific and Ethical advisory Board (SEAB) is an external consultative body which is formed to ensure and improve the scientific performance and the quality of results of PANCAID. The SEAB advises the General Assembly (GA) and the Project Management Office (PMO) upon request, and provides non-binding advice as decision making support. Members of the SEAB are cordially invited to attend the annual GA meetings in order to monitor the progress within each work packages, assess the scientific quality, and to provide critique and feedback, but do not have a right to vote. The SEAB will also consider and mention any ethical issues which may require stronger attention.

Sudhir Srivastava, Ph.D., M.P.H.

Chief | Cancer Biomarkers
Phone: 240-276-7028
send message

Aldo Scarpa

Full Professor
Phone: 045 8127457
send message

Eline Aas

Professor - Departement of Health Economics and Health Management
Phone: +47 22845036
send message

Gauthier Chassang

Lawyer at INSERM, CERPOP, Team bioethics; Head of Operations for the Genotoul Societal Platform "Ethics and Biosciences"
visit website

Impact Board (IB)

The Impact Board (IB) consists of junior and senior members of PANCAID, from academia and industry, as well as patient representatives. The IB is responsible for designing a structured communication plan for dissemination and the exploitation of the project’s results, monitor the steps being taken, and oversee and evaluate the comprehensive internal and external dissemination and societal impact of the project’s results and knowledge gain. In addition, the IB protects PANCAID’s intellectual property rights (IPR).

Dr. rer. nat. Claudia Koch

Project manager European Liquid Biopsy Society (ELBS)
Phone: +49 (0) 152 22830556
send message

Antonella Cardone

CEO of Cancer Patients Europe
visit website

Matthias Löhr MD PhD

Professor of Gastroenterology & Hepatology
Phone: +46 8 58589591
send message

Prof. Dr. med. Klaus Pantel

Director / Professor of Medicine
Phone: +49 (0) 40 7410 53503
send message

Sergio Sabroso

Biostatistician
Phone: +34 917 32 80 00
send message

Dr. med. Dr. rer. biol. hum. Daniel J. Smit

Research group leader
Phone: +49 (0) 40 7410 57495
+49 (0) 152 22815034
send message

Data Safety and Monitoring Board (DSMB)

The Data Safety and Monitoring Board is an internal supervisory body, diligently overseeing and evaluating patient safety and treatment efficacy data throughout the duration of a clinical trial. Additionally, the Board will review issues concerning the safety of the trial participants, data integrity and statistics.

Furthermore, the DSMB is responsible for identifying strengths and weaknesses of the data hub, reviewing the integrity of the data and potential statistical problems, as well as defining of Data privacy and conducting Data Privacy Impact Assessment (DPIA). The DSMB will work to a charter to be set up before the beginning of the study. Following study completion, the DSMB will assist in interpretation of the final results and approve the main study publication.

PhD, MD, Núria Malats

Principal Investigator
Phone: +34 917 32 80 00
send message

Anders Nordell, MSs

CEO
Phone: +46 70 521 86 50
send message

Univ.-Prof. Dr. med. Hans-Helmut König, MPH

Director / Professor of Health Services Research and Health Economics
Phone: +49 (0) 40 7410 - 54464
send message